*Some Market data delayed by 15 mins.

Imunon, Inc. Common Stock

Symbol: IMNN (NASDAQ)
5.04 ▼ (-2.70%) -0.140

Company Description:
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Key Stats
  • Today's Open: $5.17
  • Today's High: $5.233
  • Today's Low: $5.04
  • Today's Volume: 39.80K
  • Yesterday Close: $5.18
  • Yesterday High: $5.35
  • Yesterday Low: $5.1688
  • Yesterday Volume: 95.24K
  • Last Min Volume: 10
  • Last Min High: $5.04
  • Last Min Low: $5.04
  • Last Min VWAP: $5.04
Company Profile
  • Name: Imunon, Inc. Common Stock
  • Website: https://www.imunon.com
  • Listed Date: 1995-07-24
  • Location: LAWRENCEVILLE, NJ
  • Market Status: Active
  • CIK Number: 0000749647
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $13.06M
  • Round Lot: 100
  • Outstanding Shares: 2.52M
  • Asset Type: CS
RECENT FILINGS FOR IMNN
Filing Date Filing Type Format
2025-09-09 4 View
2025-08-28 8-K View
2025-08-13 SCHEDULE 13G/A View
2025-08-12 SCHEDULE 13G/A View
2025-08-06 4 View
2025-08-06 4 View
2025-08-06 4 View
2025-08-06 4 View
2025-08-06 4 View
2025-08-06 4 View
2025-08-06 4 View
2025-08-06 4 View
2025-08-06 4 View
2025-08-05 10-Q View
2025-08-05 8-K View
2025-07-28 8-K View
2025-07-23 8-K View
2025-07-22 8-K View
2025-07-22 424B5 View
2025-07-14 8-K View
Latest News on IMNN

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.